GLP-1 medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) have recently been gaining popularity and media attention for their beneficial effects in treating diabetes and promoting weight loss
Improved blood sugar control (slower glucose spikes)
The benefit of microdosing
Key takeaways: Hashimotos and hypothyroidism do not automatically disqualify you Only medullary thyroid cancer and MEN-2 are true contraindications Weight loss may require thyroid medication adjustment Personalized endocrine care makes all the difference Whether youre located in Lafayette, San Francisco, the Bay Area, or anywhere in California via telemedicine , these decisions for my patients are always made through thoughtful, one-on-one discussions
They found that for FDA approved GLP-1s for weight loss, liraglutide (Saxenda) and semaglutide (Wegovy), the percent of side effects reported was as follows: Nausea: 42.2% Diarrhea: 21.9% Vomiting: also 21.9% Constipation: 8.4% They report that although the incidence of side effects were similar among medications, semaglutide had the greatest risk of nausea, diarrhea, and vomiting, whereas liraglutide had the greatest risk of upper abdominal pain
Why do GLP-1 drugs cause nausea